June 10, 2019 | Events

Justin Klein featured at Virginia Bio Insights at University of Virginia Darden School of Business

17

Novel FDA PMA & de novo 510k approvals

40

U.S. Commercial Product Launches

34

Level I Clinical Trials

25

Strategic Financings

26

Exits by IPO or M&A